|
Pharmaceuticals & Advertising News is an EIN News Service for marketing and advertising professionals. Constantly updated news and information about marketing.
Latest Pharmaceuticals & Advertising News
- Advertising expenditure hits US$54 billion in China 3 Dec 2009 05:10 GMT
... BEIJING - Advertising expenditure in China for the first three ... per cent year-on-year increase, according to CTR Marketing Research. Growing on average by 14 per ... The top 10 advertisers also included Harbin Pharmaceutical, Parkson, Coca-Cola, Wahaha, China Mobile and Sanjing ...
- Provision Interactive Set to Revolutionize the Billion Dollar Advertising Market (OTC:PVHO.OB) 3 Dec 2009 02:18 GMT
... Provision Interactive Brings 3D Tactile Holographic Advertising to the Market (OTC:PVHO.OB) MiV Investments Inc. ... flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made ...
- Novartis receives approval in the European Union for Onbrez(R) Breezhaler(R), a new once-daily bronchodilator for patients with COPD 3 Dec 2009 06:51 GMT
... said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division. "The EC approval of Onbrez Breezhaler ... other current treatments[3,14,15]. The most common adverse drug reactions were nasopharyngitis, cough, upper respiratory tract ... by 2020[9]. Bronchodilators are a group of drugs that widen the airways in the lungs ...
- TargetRx Introduces New Research Capability to Increase Effectiveness of Co-Pay Card Initiatives 3 Dec 2009 14:13 GMT
... Provides Insights to Increase Usage and Maximize Marketing Investment HORSHAM, Pa.--(BUSINESS WIRE)--Nov 30, 2009 - ... WIRE)--Nov 30, 2009 - Companies marketing branded pharmaceuticals are facing an increasing need to make ... Furthermore, the rise of competition among branded drugs has led many pharmaceutical companies to focus less ...
- Successful Re-Launch of SinoFresh Nasal Spray Continues 3 Dec 2009 09:06 GMT
... testing of the product: , to enhance marketing and distribution for SinoFresh Homeopathic Antiseptic Nasal ... Dr. Michael Stampar. Further radio and television advertising is being launched throughout Florida and around ... has proven to be successful for independent pharmacies, chiropractors and Doctor's offices. The 10 Unit ...
- Novartis receives approval in the European Union for Onbrez® Breezhaler®, a new once-daily bronchodilator for patients 3 Dec 2009 07:14 GMT
... said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division. "The EC approval of Onbrez Breezhaler ... other current treatments[3,14,15]. The most common adverse drug reactions were nasopharyngitis, cough, upper respiratory tract ... by 2020[9]. Bronchodilators are a group of drugs that widen the airways in the lungs ...
- Novartis receives approval in the European Union for Onbrezî Breezhalerî, a new once-daily bronchodilator for patients with COPD 3 Dec 2009 11:24 GMT
... said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division. "The EC approval of Onbrez Breezhaler ... other current treatments[3,14,15]. The most common adverse drug reactions were nasopharyngitis, cough, upper respiratory tract ... by 2020[9]. Bronchodilators are a group of drugs that widen the airways in the lungs ...
- Novartis receives approval in the European Union for Onbrez® Breezhaler®, a new once-daily bronchodilator for patients with COPD 3 Dec 2009 13:25 GMT
... said Joe Jimenez, CEO of the Novartis Pharmaceuticals Division. "The EC approval of Onbrez Breezhaler ... other current treatments[3,14,15]. The most common adverse drug reactions were nasopharyngitis, cough, upper respiratory tract ... by 2020[9]. Bronchodilators are a group of drugs that widen the airways in the lungs ...
- Sign Up & Be in the Know!! Our Alerts are Making our Members $$!! SRGL,IMUC,CGLD,ATNP,PWRM,ENCR 3 Dec 2009 05:26 GMT
... Sign Up & Be in the Know!! Our Alerts ... (M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: SRGL) Source Gold ... Parkinson's like disorders (disease controls) and distinguish drug naive and drug treated patients. He also presented ...
- Oculus Innovative Sciences Provides 2010 U.S. Milestones Update 3 Dec 2009 13:31 GMT
... Oculus Innovative Sciences, Inc. (Nasdaq: ), a biopharmaceutical company that develops, manufactures and markets a ... (learning what triggers the allergic reactions) and drug therapy. According to the National Institute of Arthritis ... Following the successful introduction via a national advertising campaign of the Vetericyn products into the ...
- M&A Navigator: Deal Pipeline - 2 Dec 2009 3 Dec 2009 10:43 GMT
... SCRIPTS COMPLETES NEXTRX BUY FOR USD4.68BN US pharmacy benefit management (PBM) company Express Scripts (NASDAQ:ESRX) ... wrapped up the buy of NextRx, the drug benefit operations of health insurance group WellPoint (NYSE:WLP) ... COSSETTE ACCEPTS MILL ROAD SWEETENED OFFER Canadian advertising agency Cossette (TSE:KOS) said it has accepted ...
- PVHO.OB) 3 Dec 2009 01:03 GMT
... MiV Investments Inc. has initiated an independent research report ... art dating back to 4000 BC, out-of-home advertisements and billboards have dominated the main stream ... flows, contract awards, FDA announcements, trial and drug approvals, and company stability. Forward-looking statements are made ...
- ExonHit Launches First Product in Alzheimer 3 Dec 2009 06:55 GMT
... test for the detection of Alzheimer's disease (AD), is now available as a Research Use ... a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical ... launch in Q1 of 2011. Regarding US marketing approval, discussions have been initiated with the ...
- Big Communications wins two new NHS briefs 3 Dec 2009 12:30 GMT
... admitted. The campaign runs across regional press, pharmacy bag advertising and other in-hospital material including leaflets, pens, ... The regional campaign will include a TV ad focusing on education around antibiotic stewardship. Register ...
- ExonHit Launches First Product in Alzheimer (BIZ) 3 Dec 2009 09:58 GMT
... could be a tremendous asset for the pharmaceutical industry as it has the potential to ... benefit the most from therapeutic advances in AD." AclarusDx(TM) Alzheimer's test is a reproducible, objective, ... launch in Q1 of 2011. Regarding US marketing approval, discussions have been initiated with the ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Marketing & Advertising Industry Today
|
a digital news provider
media.asia:
nytimes.com:
adage.com:
brandrepublic.com: